REQUEST A DEMO
Total
USD $0.00
Search more companies

Ventus Pharmaceuticals Private Limited (India)

Main Activities: Plastics Material and Resin Manufacturing
Full name: Ventus Pharmaceuticals Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Ventus Pharmaceuticals Private Limited is an enterprise based in India. Its main office is in Panchkula. The company operates in the Plastics Material and Resin Manufacturing industry. The company was established on November 14, 2011. In 2025, the company reported a net sales revenue increase of 12.01%. Its’ total assets recorded a growth of 4.14%. In, 2025, the company’s net profit margin increased by 0.06%.

Legal Address
P.No 216,Hsidc Alipur
Panchkula; Haryana; Postal Code: 134118

Contact Details: Purchase the Ventus Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Ventus Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Ventus Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
November 14, 2011
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Ventus Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
12.01%
Total Operating Revenue
11.93%
Operating Profit
22.05%
EBITDA
14.73%
Net Profit/Loss for the Period
14.46%
Total Assets
4.14%
Total Equity
20%
Operating Profit Margin
0.49%
Net Profit Margin
0.06%
Return on Equity (ROE)
-0.81%
Debt / Equity
-90.66%
Quick Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?